Cite Filings / FULC / 0001193125-26-458387
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Fulcrum Therapeutics, Inc. · Filed 2026-11-12 · Acc 0001193125-26-458387

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , d137296d8k.htm

Around this filing

  • 2026-11-16 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-11-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-11-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-11-12 10-Q Quarterly Report
  • 2026-11-12 425 Prospectus/Communication re Business Combination
  • 2026-11-12 8-K Other events
  • 2026-08-17 8-K Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d137296d8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…